Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Virani Shafique Create: Alert

All | News | Filings
Date FiledTypeDescription
08/17/2023 4 Virani Shafique (Chief Business Officer) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 3,603 shares @ $9.19, valued at $33.1k
Sold 18,000 shares @ $9.25, valued at $166.5k
Exercised 18,000 options to buy @ $2.22, valued at $40k
08/15/2023 144 Form 144 - Report of proposed sale of securities:
07/27/2023 4 Virani Shafique (Chief Business Officer) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 20,000 shares @ $14.3, valued at $286k
Sold 20,000 shares @ $14.41, valued at $288.2k
Exercised 20,000 options to buy @ $2.22, valued at $44.4k
Exercised 20,000 options to buy @ $2.22, valued at $44.4k
07/26/2023 144 Form 144 - Report of proposed sale of securities:
07/25/2023 144 Form 144 - Report of proposed sale of securities:
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/18/2023 144 Form 144 - Report of proposed sale of securities:
07/17/2023 144 Form 144 - Report of proposed sale of securities:
06/16/2023 144 Form 144 - Report of proposed sale of securities:
06/05/2023 4 Virani Shafique (Chief Business Officer) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 25,000 shares @ $8.58, valued at $214.5k
Sold 17,865 shares @ $8.93, valued at $159.5k
06/02/2023 144 Form 144 - Report of proposed sale of securities:
06/01/2023 144 Form 144 - Report of proposed sale of securities:
05/17/2023 4 Virani Shafique (Chief Business Officer) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 2,230 shares @ $5.6, valued at $12.5k
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/19/2023 4 Virani Shafique (Chief Business Officer) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 10,000 shares @ $9.1561, valued at $91.6k
Exercised 5,000 options to buy @ $2.22, valued at $11.1k
12/19/2022 4 Virani Shafique (Chief Business Officer) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 10,000 shares @ $8.8525, valued at $88.5k
Exercised 5,000 options to buy @ $2.22, valued at $11.1k
11/17/2022 4 Virani Shafique (Chief Business Officer) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 613 shares @ $11.86, valued at $7.3k
Sold 5,059 shares @ $12.7, valued at $64.2k
Sold 4,941 shares @ $11.9153, valued at $58.9k
Exercised 5,000 options to buy @ $2.22, valued at $11.1k
10/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/16/2022 4 Virani Shafique (Chief Business Officer) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 9,600 shares @ $13.3381, valued at $128k
Sold 400 shares @ $13.9725, valued at $5.6k
Exercised 5,000 options to buy @ $2.22, valued at $11.1k
08/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/15/2021 3 Form 3 - Initial statement of beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy